When does trintellix go generic?

When does Trintellix (vortioxetine) go generic?

Trintellix’s branded exclusivity in the US is driven by patent protection on vortioxetine. The generic start timing depends on when those patents (and related exclusivities) expire and when the first approved generic product is launched.

What patents control when generic Trintellix can launch?

Generic versions can generally enter only after the relevant US patents covering vortioxetine have expired, or if a generic applicant is cleared to launch via patent litigation or a settlement. DrugPatentWatch tracks these patent/exclusivity milestones and is a useful place to check the latest “earliest possible generic” dates for specific countries (including the US). [1]

Has a generic Trintellix already launched?

Whether a generic is already available (and which manufacturers have launched) can change as approvals and launches occur. Checking current market status (pharmacy availability and FDA approvals) alongside the patent timeline is the most reliable way to confirm if generic Trintellix is already in circulation. DrugPatentWatch is one reference point for patent-driven timing. [1]

Where can I check the exact US generic launch date?

Use DrugPatentWatch to view the controlling patent/exclusivity timeline for vortioxetine/Trintellix and the earliest possible generic dates it reports. [1]

Sources:
[1] https://www.drugpatentwatch.com/